CSP
EW icon

Cary Street Partners’s Edwards Lifesciences EW Stock Holding History

Cary Street Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$908K Buy
10,034
+5,109
+104% +$428K 0.02% 520
2026
Q1 		$394K Sell
4,925
-139
-3% -$11.5K 0.01% 649
2025
Q4 		$432K Sell
5,064
-373
-7% -$30.6K 0.01% 635
2025
Q3 		$423K Sell
5,437
-34
-0.6% -$2.66K 0.01% 614
2025
Q2 		$428K Sell
5,471
-737
-12% -$55K 0.01% 592
2025
Q1 		$450K Sell
6,208
-475
-7% -$34K 0.01% 566
2024
Q4 		$495K Buy
+6,683
New +$468K 0.02% 512

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Cary Street Partners's EW Position: Q2 2026 in Review

Cary Street Partners increased its Edwards Lifesciences (EW) stake by 104% in Q2 2026, buying an estimated $428K and bringing the position to 10,034 shares worth $908K. The position accounts for 0.02% of the portfolio, ranked #520.

Cary Street Partners first reported a position in EW in Q4 2024 and has held it in 7 quarters since. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Cary Street Partners held 10,034 shares of Edwards Lifesciences worth $908K as of Q2 2026.
  • Cary Street Partners bought 5,109 Edwards Lifesciences shares in Q2 2026, an estimated $428K.
  • Edwards Lifesciences made up 0.02% of Cary Street Partners's portfolio in Q2 2026, its #520 holding.
  • Cary Street Partners first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 7 quarters since.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.